Mindray Launches Reliable hs-cTnI and NT-proBNP Assays

Mindray has launched reliable high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. It’s the outcome of a fruitful collaboration between Mindray and HyTest, a prominent global provider of antibodies and antigens acquired by Mindray in 2021. The two new assays have enhanced Mindray’s diverse portfolio of cardiac biomarkers for diagnosing and managing cardiovascular diseases (CVDs). Watch the global launch event to find out more.